In conclusion, ACSL1 is potentially a prognostic and diagnostic factor for ccRCC sufferers, and the variances in ACSL1 expression between ccRCC and other tumors may account for the different tumorigenesis mechanisms of ACSL1 in diverse cancer types. This evidence concerns the gene ACSL1 and nonpapillary renal cell carcinoma.